Galera Therapeutics Inc. (GRTX)
OTC: GRTX
· Real-Time Price · USD
0.03
0.00 (9.09%)
At close: Apr 04, 2025, 2:24 PM
Galera Therapeutics Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -5.58M | -4.06M | -4.38M | -5.59M | -15.07M | -20.71M | -17.71M | -16.19M | -16.03M | -14.56M | -15.44M | -16.81M | -22.63M | -22.39M | -18.71M |
Depreciation & Amortization | 5K | 6K | 9K | 215K | 12K | 12K | 20K | 26K | 27K | 30K | 31K | 464K | 106K | 102K | 106K |
Stock-Based Compensation | 551K | 723K | 875K | 1.19M | 1.39M | 1.52M | 1.46M | 1.74M | 1.75M | 1.83M | 1.85M | 1.96M | 1.87M | 1.61M | 1.79M |
Other Working Capital | 1.19M | 852K | -965K | -4.09M | 864K | 1.28M | -2.01M | -2.76M | 1.8M | 1.66M | 789K | -3.24M | 1.01M | 3.51M | -3.81M |
Other Non-Cash Items | 11.86M | n/a | 1.22M | 4.66M | 2.09M | 7.64M | 4.22M | 3.32M | 3.25M | 2.7M | 2.3M | 2.31M | 2.33M | 1.3M | 1.25M |
Deferred Income Tax | n/a | n/a | n/a | -3.96M | n/a | -72K | n/a | -70K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 676K | 618K | -1.29M | -6.43M | -937K | 860K | 343K | -2.77M | 1.8M | 1.11M | -124K | -5.37M | -81K | 2.57M | 262K |
Operating Cash Flow | 7.51M | -2.72M | -4.79M | -9.91M | -12.52M | -10.75M | -11.67M | -13.95M | -9.21M | -8.89M | -11.38M | -17.45M | -18.4M | -16.8M | -15.3M |
Capital Expenditures | n/a | n/a | n/a | -9K | n/a | -50K | n/a | n/a | -5K | -7K | -13K | -53K | -25K | -19K | -186K |
Cash Acquisitions | n/a | n/a | n/a | -3.98K | n/a | -7.6K | n/a | n/a | -4.61K | -6.62K | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | -16K | -4.03M | -6.15M | -12.45M | -12.97M | -12.39M | -18.88M | -15.65M | -4.8M | -60.02M | -236K | -6.93M |
Sales Maturities Of Investments | n/a | n/a | n/a | 4M | 14.49M | 13.75M | 17.75M | 15.75M | 17M | 25.5M | 25.66M | 24.5M | 17M | 16M | 20M |
Other Investing Acitivies | 4K | n/a | n/a | 3.98K | 10.46K | 7.6K | n/a | 2.78K | 4.61K | 6.62K | 10.01M | 19.7M | -43.02M | 15.76M | 13.07M |
Investing Cash Flow | 4K | n/a | n/a | 3.98M | 10.46M | 7.55M | 5.3M | 2.78M | 4.6M | 6.62M | 10M | 19.65M | -43.04M | 15.74M | 12.88M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | n/a | n/a | 201K | 1.81M | 184K | 11K | 10K | 2K | 58K | 22K | 38.39M | 20.12M | 235K |
Financial Cash Flow | n/a | n/a | n/a | -232K | 2.13M | 1.81M | 27.78M | 2.7M | 10K | 2K | 1.18M | 22K | 40.61M | 25.84M | 235K |
Net Cash Flow | -2.29M | -2.72M | -4.79M | -6.17M | 77K | -1.39M | 21.42M | -8.46M | -4.6M | -2.27M | -214K | 2.23M | -20.83M | 24.78M | -2.19M |
Free Cash Flow | 7.51M | -2.72M | -4.79M | -9.92M | -12.52M | -10.8M | -11.67M | -13.95M | -9.21M | -8.89M | -11.4M | -17.5M | -18.43M | -16.82M | -15.49M |